- Open
- 0.30
- High
- 0.32
- Low
- 0.29
- Close
- 0.32
- Change
- -0.01 (-1.96%)
- Volume
- 18,970,945
⌘K
| 14 Jan 2025 | 07:00:07 | Change of Name to Solvonis Therapeutics plc |
| 6 Jan 2025 | 14:27:38 | Result of General Meeting and change of name |
| 18 Dec 2024 | 07:00:07 | Proactive Investors Interview with CEO and Chair |
| 16 Dec 2024 | 07:00:05 | Proposed acquisition of Awakn Life Sciences Corp |
| 11 Dec 2024 | 07:00:03 | Initial Results University of Nottingham |
| 30 Apr 2025 | Annual Financial Report 31 December 2024 | |
| 14 May 2024 | Annual Financial Report - 31.12.22 |
Graft Polymer (UK) Plc (LSE: GPL) was founded in 2017 by a team of specialists in polymer technology and investors. The primary focus of Graft Polymer is on polymer modification and the creation of innovative drug delivery solutions.
| 14 Jan 2025 | 07:00:07 | Change of Name to Solvonis Therapeutics plc |
| 6 Jan 2025 | 14:27:38 | Result of General Meeting and change of name |
| 18 Dec 2024 | 07:00:07 | Proactive Investors Interview with CEO and Chair |
| 16 Dec 2024 | 07:00:05 | Proposed acquisition of Awakn Life Sciences Corp |
| 11 Dec 2024 | 07:00:03 | Initial Results University of Nottingham |
| 30 Apr 2025 | Annual Financial Report 31 December 2024 | |
| 14 May 2024 | Annual Financial Report - 31.12.22 |
Graft Polymer (UK) Plc (LSE: GPL) was founded in 2017 by a team of specialists in polymer technology and investors. The primary focus of Graft Polymer is on polymer modification and the creation of innovative drug delivery solutions.